GlaxoSmithKline CEO Andrew Witty

Andrew Witty, GlaxoSmithKline CEO

GlaxoSmithKline appointed Andrew Witty to succeed Jean-Pierre Garnier as CEO. He took over in may. Witty has spent his entire career at Glaxo, with stints in South Africa, the U.S., and Asia. He was previously president of the company's European pharma division.

Read more on